SCHEMBL170136

SCHEMBL170136

Cc1ccccc1[Mg]Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31463495 1.00
Bromide SCHEMBL362697 0.97 TSHR (0.45)
Hydrochloric Acid SCHEMBL7667954 0.97 TSHR (0.45)
SCHEMBL1314594 0.79 TRPA1 (0.42)
SCHEMBL464794 0.77 TSHR (0.53)
O-Xylene SCHEMBL27638879 0.76 TSHR (0.71)
SCHEMBL1314056 0.72
SCHEMBL29881812 0.72
Bromide SCHEMBL4662619 0.72 TSHR (0.47)
SCHEMBL959600 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025242747-A1 MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS MERCK PATENT GMBH (DE) 2025-11-27 WO claimed
US-20250282729-A1 CHEMICAL COMPOUND MANUFACTURE, NEW SALT FORM, AND THERAPEUTIC USES THEREOF EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO) (AU) 2025-09-11 US claimed
US-12351557-B2 Chemical compound manufacture, new salt form, and therapeutic uses thereof EUSTRALIS PHARMACEUTICALS LIMITED (AU) 2025-07-08 US claimed
CN-114181142-B Synthesis method of 6- (4-methylpiperazine-1-yl) -4-o-tolylpropionic nicotinamide 浙江工业大学 2023-10-20 CN claimed
CN-114181142-A Synthetic method of 6- (4-methylpiperazine-1-yl) -4-o-tolylnicotinamide 浙江工业大学 2022-03-15 CN claimed
US-20220073467-A1 Chemical Compound Manufacture, New Salt Form, And Therapeutic Uses Thereof EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO) (AU) 2022-03-10 US claimed
EP-3902793-A1 CHEMICAL COMPOUND MANUFACTURE, NEW SALT FORM, AND THERAPEUTIC USES THEREOF Eustralis Pharmaceuticals Limited (Trading as Pressura Neuro) (AU) 2021-11-03 EP claimed
WO-2020132716-A1 CHEMICAL COMPOUND MANUFACTURE, NEW SALT FORM, AND THERAPEUTIC USES THEREOF EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO) (AU) 2020-07-02 WO claimed
US-8609574-B2 In situ olefin polymerization catalyst system PROMERUS LLC (US) 2013-12-17 US claimed
EP-2296811-A2 IN SITU OLEFIN POLYMERIZATION CATALYST SYSTEM Promerus, LLC (US) 2011-03-23 EP claimed
US-20060211896-A1 Process for producing 4-(2-methylphenyl)benzotrifluoride SUMITOMO CHEMICAL COMPANY, LIMITED 2006-09-21 US claimed
EP-1700837-A1 Process for producing 4-(2-methylphenyl)benzotrifluoride Sumitomo Chemical Company, Limited (JP) 2006-09-13 EP claimed
EP-1594824-A2 PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF Atherogenics, Inc. (US) 2005-11-16 EP claimed
US-20040204485-A1 Process of preparing esters and ethers of probucol and derivatives thereof CRABTREE ACQUISITION CO, LLC 2004-10-14 US claimed
WO-2004062622-A2 PROCESS OF PREPARING ESTERS AND ETHERS OF PROBUCOL AND DERIVATIVES THEREOF ATHEROGENICS, INC. (US) 2004-07-29 WO claimed
US-20010034459-A1 Process for preparing 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethyl-biphenyl-2-carboxylic acid from o-tolylmetallates MEUDT ANDREAS (DE) 2001-10-25 US claimed
EP-1112991-A2 Process for the preparation of 4'-trifluoromethyl-2-methylbiphenyl and 4'-trifluoromethylbiphenyl-2-carboxylic acid from o-tolylmetallates Clariant GmbH (DE) 2001-07-04 EP claimed
WO-2001044147-A1 PROCESS FOR THE PREPARATION OF 2-METHYLBIPHENYL AND OF 2-PHENYLBENZYL BROMIDE ALBEMARLE CORPORATION (US) 2001-06-21 WO claimed
US-4902833-A Bisphosphine dioxides UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (US) 1990-02-20 US claimed
EP-0152450-B1 CATALYZED GRIGNARD COUPLING PROCESS FMC Corporation (US) 1989-05-03 EP claimed